Psychopharmacology and Psychiatry Updates

En podcast af Psychopharmacology Institute

Kategorier:

242 Episoder

  1. Preventing Depression and Anxiety Relapse in Youth

    Udgivet: 1.5.2024
  2. Charting the Clozapine Course: Titration and Monitoring

    Udgivet: 26.4.2024
  3. Smoking and Psychosis: Insights from the PATH Study

    Udgivet: 21.4.2024
  4. Clozapine: The Gold Standard for Treatment-Resistant Schizophrenia

    Udgivet: 16.4.2024
  5. Balancing Benefits and Risks: Lithium in Child and Adolescent Psychiatry

    Udgivet: 11.4.2024
  6. Orchestrating Nutrition and Medication: Micronutrient Therapy in Practice

    Udgivet: 6.4.2024
  7. Zuranolone: A New Dawn for Postpartum Depression Treatment

    Udgivet: 1.4.2024
  8. Micronutrients for Psychiatric Disorders: Optimizing Clinical Use

    Udgivet: 27.3.2024
  9. Olanzapine in Pregnancy: Examining the Risks

    Udgivet: 22.3.2024
  10. Understanding Safety Risks of Broad-Spectrum Micronutrients

    Udgivet: 17.3.2024
  11. The Role of Inflammation in Delirium: Can NSAIDs Help?

    Udgivet: 12.3.2024
  12. Beyond Medication: Exploring Nutritional Psychiatry

    Udgivet: 7.3.2024
  13. Age Impact on Antidepressant Outcomes

    Udgivet: 2.3.2024
  14. Dealing With Delirium in Patients With Advanced Cancer

    Udgivet: 26.2.2024
  15. Rechallenging Clozapine: A Look at Colony Stimulating Factors

    Udgivet: 21.2.2024
  16. Managing Anxiety in Patients With Cancer

    Udgivet: 16.2.2024
  17. Managing Antidepressant Side Effects in Youth

    Udgivet: 11.2.2024
  18. Depressed Patient With Cancer? Here’s How to Treat

    Udgivet: 6.2.2024
  19. Brexanolone: A Quick Fix for Postpartum Depression and Anxiety?

    Udgivet: 1.2.2024
  20. The Nitty-Gritty on Treatment Optimization for Tic Disorders in Youth

    Udgivet: 27.1.2024

3 / 13

Practical psychopharmacology updates for mental health clinicians. Useful for psychiatry / mental health professionals. Expert interviews and soundbites from CME presentations. Practical and free of commercial bias. Not sponsored by any pharmaceutical company.

Visit the podcast's native language site